L8L-25159-93878
2 vaccinations
1 coded response
22 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 41-45
- ZIP prefix
- 222 / VA
- Registered
- 2021-03-03
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-03
Registered in v-safe
-
2021-03-03
Dose 1 — Moderna
- 2021-03-03
- 2021-03-04
- 2021-03-05
- 2021-03-06
- 2021-03-07
- 2021-03-08
- 2021-03-09
- 2021-03-10
- 2021-03-17
- 2021-03-26
- 2021-03-31
-
2021-04-06
Dose 2 — Moderna
- 2021-04-07
- 2021-04-09
- 2021-04-10
- 2021-04-11
- 2021-04-12
- 2021-04-21
- 2021-04-27
- 2021-05-06
- 2021-05-11
- 2021-07-06
-
2021-10-05
Survey response — 6 months, dose 2MedDRA: Lacrimation increased, Oropharyngeal pain, Rhinorrhoea, Sneezing — Feeling: GoodFree text: Sore throat, runny nose, watery eyes, sneezingMedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-03 | Moderna | |
| 2 | 2021-04-06 | Moderna |
Free text
Release 10 — 6 months, dose 2
Symptoms: Sore throat, runny nose, watery eyes, sneezing
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Lacrimation increased | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
| SD | Sneezing | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release